Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

New dyslipidemia guidance from the American Association of Clinical Endocrinology focuses on newer medications and ...

Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...

A drug commonly used to treat high blood pressure, nifedipine, may pose more risks than previously thought, according to a ...

For a long time, there have been concerns that beta-blockers might cause mental health problems like depression, anxiety, and ...

Numbers released by the Heart Failure Society of America in September 2024 reveal that approximately 6.7 million Americans ...

New heart health biopharmaceutical company Kardigan, which counts among its co-founders the director for Northwestern ...